GS0411: Educational services, namely, conducting classes, seminars, and workshops in the field of pharmaceutical preparations and medicines, medical devices and techniques; Educational services, namely, conducting classes, seminars, workshops and training for doctors, nurses and others in the fields of critical care, critical testing, maternal health, rare diseases and conditions, anesthesia, and aesthetic solutions to help patients feel better about their bodies
GS0401: Manufacture of pharmaceutical products to order and specification of others; Providing technical information in the field of pharmaceutical manufacturing
DM0000: The mark consists of a hexagon shape on an angle with intermittent solid vertical lines, with the words "ENDO GENERICS" in lower case font to the right and the words "PAR PHARMACEUTICAL" in title case font underneath.
GS0051: Pharmaceutical and medical preparations and ready-to-administer injectable pharmaceutical and medical preparations in connection with critical care, critical testing, maternal health, anesthesia, and for the treatment of pain, allergic reactions, hypotension, shock, malignant diseases, kidney disorders, cellulite, skin care, dermatological use, folds, scars, and body contouring and for rejuvenating the skin, and to provide and reverse muscle relaxation, all to be used in patient care facilities, namely, hospitals, acute care facilities, and long term care facilities and in doctor's offices; Pharmaceutical preparations, namely, analgesics and pain management preparations, preparations for the treatment of cancers, preparations for the treatment of urological diseases and disorders, preparations for the treatment of schizophrenia; pharmaceutical preparations for the treatment of asymmetries and defects in conditions of the human skin; pharmaceutical preparations for the treatment of diseases and disorders of the endocrine system, hormone replacement therapy preparations; drug substances, namely, enzymes for medical purposes; pharmaceutical preparations for the treatment of cellulite; pharmaceutical preparations for skin care; medicated gels and creams for dermatological use; nutritional and dietary supplements; vitamins and mineral supplements; food supplements
CC0000: Color is not claimed as a feature of the mark.
GS0441: Providing medical information and online medical information on the subjects of pharmaceutical preparations and medicines, medical devices and techniques; Providing medical information and online medical and healthcare information to healthcare professionals and patients; Providing a website featuring medical information; Providing medication counseling information, namely, advice and data on the subjects of pharmaceutical preparations and medicine
DS0000: "GENERICS" AND "PHARMACEUTICAL"
GS0101: Medical devices for use in treating pelvic disorders; Medical devices for use in treating pelvic organ prolapse; Medical devices for use in treating urinary incontinence; Medical devices for use in pain management and alleviation; Medical devices, namely, surgical equipment in the fields of urology and men's health; Medical devices, namely, intrauterine devices; Injection syringes; Injection device for pharmaceuticals and medicine
GS0421: Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Medical research in the fields of chemicals and pharmaceuticals; Scientific research and testing services in the fields of chemicals and pharmaceuticals; Research and development of new products for others in the fields of chemicals and pharmaceuticals; Development of pharmaceutical products to specifications of others
Case File Event Statements
3/21/2022 - 4 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTEREDType:NWOS
3/18/2022 - 4 years ago
1 - NEW APPLICATION ENTEREDType:NWAP
3/22/2022 - 4 years ago
3 - NOTICE OF DESIGN SEARCH CODE E-MAILEDType:MDSC
5/10/2022 - 4 years ago
4 - ASSIGNED TO EXAMINERType:DOCK
5/16/2022 - 4 years ago
5 - NON-FINAL ACTION WRITTENType:CNRT
5/16/2022 - 4 years ago
6 - NON-FINAL ACTION E-MAILEDType:GNRT
5/16/2022 - 4 years ago
7 - NOTIFICATION OF NON-FINAL ACTION E-MAILEDType:GNRN
8/2/2022 - 3 years ago
8 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
8/2/2022 - 3 years ago
9 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
8/2/2022 - 3 years ago
10 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
8/23/2022 - 3 years ago
11 - SUSPENSION LETTER WRITTENType:CNSL
8/23/2022 - 3 years ago
12 - LETTER OF SUSPENSION E-MAILEDType:GNSL
8/23/2022 - 3 years ago
13 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILEDType:GNS3
11/18/2022 - 3 years ago
14 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVEDType:ERSI
1/19/2023 - 3 years ago
15 - ASSIGNED TO LIEType:ALIE
1/20/2023 - 3 years ago
16 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
1/20/2023 - 3 years ago
17 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
1/23/2023 - 3 years ago
18 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
2/8/2023 - 3 years ago
19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDType:NONP
2/28/2023 - 3 years ago
20 - PUBLISHED FOR OPPOSITIONType:PUBO
2/28/2023 - 3 years ago
21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDType:NPUB
5/16/2023 - 3 years ago
22 - REGISTERED-PRINCIPAL REGISTERType:R.PR
5/16/2023 - 3 years ago
23 - NOTICE OF REGISTRATION CONFIRMATION EMAILEDType:NRCC
5/1/2024 - 2 years ago
24 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIPType:ASGN